Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) Profit Metrics

Price: $24.82
Market Cap: $24.82B
Avg Volume: 3.31M
Country: MX
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.525
52W Range: $13.9-29.18
Website: Genomma Lab Internacional, S.A.B. de C.V
Profit Metrics Summary (Annual)

According to Genomma Lab Internacional, S.A.B. de C.V's latest annual financial reports:

  • The company has reported a gross profit of 11.93B, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 64.12%, with a year-over-year growth of 18.33%.
  • Genomma Lab Internacional, S.A.B. de C.V's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 4.14B. The EBITDA margin stands at 22.24%, showing a growth of 46.65% compared to the previous year.
  • The operating income, representing the profit from business operations before taxes and interest, stands at 3.98B. The operating margin is 21.40%, with a year-over-year growth of 22.17%.
  • The net income, which shows the company's total earnings or profit after all expenses, is 2.14B. The net profit margin is 11.49%, demonstrating a growth of 97.00% from the previous year.

These metrics provide a comprehensive overview of Genomma Lab Internacional, S.A.B. de C.V's profitability and operational efficiency over the past year.

Gross Profit

$11.93B

Gross Profit Margin (2023)

64.12%

EBITDA

$4.14B

EBITDA Margin

22.24%

Operating Income (2023)

$3.98B

Operating Margin

21.40%

Net Income

$2.14B

Net Profit Margin

11.49%

Historical Gross Profit
$15.00B$15.00B$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00Gross Profit20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Gross Profit Margin
166.78%166.78%111.18%111.18%55.59%55.59%0.00%0.00%Gross Profit Margin2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Gross Profit Growth
300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%Gross Profit Growth2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA
$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00-$1.00B-$1.00B-$2.00B-$2.00BEBITDA20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical EBITDA Margin
29.38%29.38%19.88%19.88%10.37%10.37%0.87%0.87%-8.63%-8.63%-18.14%-18.14%EBITDA Margin2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical EBITDA Growth
400.00%400.00%300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%EBITDA Growth2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Operating Income
$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00-$1.00B-$1.00B-$2.00B-$2.00BOperating Income20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Operating Profit Margin
28.68%28.68%19.32%19.32%9.95%9.95%0.59%0.59%-8.77%-8.77%-18.14%-18.14%Operating Profit Margin2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Operating Income Growth
400.00%400.00%300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%Operating Income Growth2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Net Income
$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00-$1.00B-$1.00B-$2.00B-$2.00BNet Income20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Historical Net Profit Margin
19.62%19.62%12.39%12.39%5.17%5.17%-2.06%-2.06%-9.28%-9.28%-16.51%-16.51%Net Profit Margin2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Net Income Growth
300.00%300.00%200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%Net Income Growth2006200620072007200820082009200920102010201120112012201220132013201420142015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Genomma Lab Internacional, S.A.B. de C.V Historical Profit Metrics
Gross Profit
EBITDA
Operating Income
Net Income
$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00-$3.00B-$3.00BProfit Metrics20062006200720072008200820092009201020102011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024
Genomma Lab Internacional, S.A.B. de C.V Historical Profits

The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.

Year Gross Profit Gross Profit Growth Operating Income Operating Income Growth Net Income Net Income Growth EBITDA EBITDA Growth
2024 $11.93B 18.33% $3.98B 22.17% $2.14B 97.00% $4.14B 46.65%
2023 $10.08B -0.79% $3.26B 0.45% $1.08B -21.90% $2.82B -6.23%
2022 $10.16B 6.28% $3.25B 6.52% $1.39B 6.22% $3.01B 6.10%
2021 $9.56B 11.35% $3.05B 10.06% $1.31B -6.81% $2.84B -6.58%
2020 $8.59B 6.05% $2.77B 18.76% $1.40B 83.59% $3.04B 32.35%
2019 $8.10B 4.29% $2.33B 1.29% $764.46M -31.10% $2.29B -4.38%
2018 $7.76B -4.39% $2.30B -9.10% $1.11B -13.27% $2.40B -11.74%
2017 $8.12B 5.73% $2.53B 251.86% $1.28B 176.10% $2.72B 346.56%
2016 $7.68B 5.72% $-1.67B -70.93% $-1.68B -57.31% $-1.10B -16.81%
2015 $7.27B -9.21% $-975.22M -139.88% $-1.07B -173.97% $-943.89M -136.64%
2014 $8.00B 0.73% $2.45B -16.75% $1.44B -17.95% $2.58B -13.22%
2013 $7.94B 17.91% $2.94B 17.85% $1.76B 17.06% $2.97B 16.11%
2012 $6.74B 20.05% $2.49B 21.14% $1.50B 6.22% $2.56B 17.62%
2011 $5.61B 26.15% $2.06B 27.40% $1.42B 29.55% $2.17B 28.18%
2010 $4.45B 39.60% $1.61B 48.05% $1.09B 43.80% $1.70B 50.87%
2009 $3.19B -3.18% $1.09B 44.63% $760.04M 47.36% $1.12B 45.82%
2008 $3.29B 139.53% $754.11M 66.46% $515.78M 69.44% $770.77M 67.48%
2007 $1.37B -19.92% $453.03M 76.54% $304.40M 68.83% $460.21M 76.21%
2006 $1.72B 217.44% $256.61M 304.28% $180.30M 257.68% $261.17M 307.91%
2005 $540.63M 0.00% $-125.62M 0.00% $-114.34M 0.00% $-125.62M 0.00%

Related Metrics

Explore detailed financial metrics and analysis for LABB.MX.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio